Update) Advanced Pathophysiology
Questions with Verified Answers | 100%
Correct |Graded A- UTA.
When do neutrophils show at the injury site?
I,- I,- I,- I,- I,- I,- I,- I,-I,- I,- 6-8 hours I,-
When do monocytes show at the injury site?
I,- I,- I,- I,- I,- I,- I,- I,-I,- I,- 1-7 days I,-
Inflammatory process I,- I,-I,- I,- -foundational concept I,-
-target of inhibition for many medications and treatments
I,- I,- I,- I,- I,- I,- I,-
-starts with cellular injury then triggers five initial steps
I,- I,- I,- I,- I,- I,- I,- I,-
First 5 steps of inflammatory process
I,- I,- I,- I,- I,- I,-I,- I,- -mast cell degranulation I,- I,-
-activation of coagulation cascade I,- I,- I,-
-activation of kinin cascade I,- I,- I,-
-release of chemotactic factors
I,- I,- I,-
-activation of complement cascade I,- I,- I,-
Complement Cascade Activated I,- I,- I,-I,- I,- -MAC-lysis of bacteria I,- I,-
,-C2b-increase vasodilation and vascular permeability I,- I,- I,- I,-
-C3a/C5a/C4a-triggers mast cell degranulation I,- I,- I,-
-C5a-attracts neutrophils (chemotaxis) I,- I,-
-C3b-enhances opsonization I,-
Kinin system activated
I,- -turned in to bradykinin which is
I,- I,-I,- I,- I,- I,- I,- I,- I,- I,-
released and responsible for pain, chemotaxis, and increase
I,- I,- I,- I,- I,- I,- I,- I,-
vascular permeability and vasodilation
I,- I,- I,-
Coagulation cascade activated I,- I,- I,-I,- I,- -has role in activating kinin
I,- I,- I,- I,- I,-
and complement system
I,- I,-
-Factor XII (Hageman factor) activates kinin
I,- I,- I,- I,- I,-
-ultimate function is to form fibrin mesh to stop bleeding and
I,- I,- I,- I,- I,- I,- I,- I,- I,- I,- I,-
trap microorganisms
I,-
Released chemotactic factors attract:
I,- -neutrophils, I,- I,- I,-I,- I,- I,-
eosinophils, and monocytes all of which begin to perform
I,- I,- I,- I,- I,- I,- I,- I,- I,-
phagocytosis
-will eventually die and rupture releasing their intracellular
I,- I,- I,- I,- I,- I,- I,- I,-
contents
-triggers release of acute phase reactants
I,- I,- I,- I,- I,-
,Mast cell degranulation
I,- -major step of inflammatory cascade
I,- I,-I,- I,- I,- I,- I,- I,- I,-
and has effect on every other aspect
I,- I,- I,- I,- I,- I,-
-leads to activation of acute phase reactants
I,- I,- I,- I,- I,- I,-
-results in release of histamine, cytokines, leukotrienes, and
I,- I,- I,- I,- I,- I,- I,- I,-
prostaglandins
acute phase reactants
I,- I,- I,-I,- I,- -coagulation proteins I,-
-kinin
-complement
histamine I,-I,- I,- -responsible for vasodilation I,- I,-
-increases vascular permeability I,- I,-
-increases blood flow to injury causing erythema and swelling
I,- I,- I,- I,- I,- I,- I,- I,-
cytokines I,-I,- I,- -can react quickly or be delayed
I,- I,- I,- I,- I,-
-IL4 released early
I,- I,- I,-
-IL3 released later
I,- I,-
-TNF released early and late
I,- I,- I,- I,-
leukotrienes I,-I,- I,- -released when mast cell degranulates I,- I,- I,- I,-
-known as slow reaction substances of anaphylaxis (SRS-A)
I,- I,- I,- I,- I,- I,- I,-
, -prolong inflammatory response I,- I,-
-cause vasodilation I,-
-attract neutrophils, monocytes, and eosiniophils
I,- I,- I,- I,-
-target of inhibition for singulair
I,- I,- I,- I,-
prostaglandins I,-I,- I,- -released in mast cell degranulation I,- I,- I,- I,-
-produced by arachidonic pathway I,- I,- I,-
-cause vasodilation, platelet aggregation at injury site, fever and
I,- I,- I,- I,- I,- I,- I,- I,- I,-
pain
monocytes additional functions I,- I,- I,-I,- I,- -become macrophages when I,- I,- I,-
they enter tissueI,- I,-
-responsible for presenting antigens to CD4 cell which triggers T
I,- I,- I,- I,- I,- I,- I,- I,- I,- I,-
cell immunity
I,- I,-
-T cell immunity goes on the trigger B cell immunity
I,- I,- I,- I,- I,- I,- I,- I,- I,-
monocytes release which cytokines I,- I,- I,- I,-I,- I,- -IL1
-IL6
-TNF
-growth factors I,-
IL1 I,-I,- I,- -causes fever I,-